title: Platelet-active drugs: the relationships among dose, effectiveness, and side effects.
authors.affiliation: Univ degli Studi GD'Annunzio, Chieti, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Patrono
authors.forename: B
authors.initials: B
authors.lastname: Coller
authors.forename: J E
authors.initials: JE
authors.lastname: Dalen
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: M
authors.initials: M
authors.lastname: Gent
authors.forename: L A
authors.initials: LA
authors.lastname: Harker
authors.forename: J
authors.initials: J
authors.lastname: Hirsh
authors.forename: G
authors.initials: G
authors.lastname: Roth
mesh_terms: D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004176:Dipyridamole / Q000009:adverse effects / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D013988:Ticlopidine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D016861:Cyclooxygenase Inhibitors; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D004176:Dipyridamole; D013988:Ticlopidine; D001241:Aspirin